Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phage-inspired antibiotics?

× No keyword cloud information.

18 in total

1. Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms.

Authors: R Briandet; P Lacroix-Gueu; M Renault; S Lecart; T Meylheuc; E Bidnenko; K Steenkeste; M-N Bellon-Fontaine; M-P Fontaine-Aupart
Journal: Appl Environ Microbiol Date: 2008-02-01 Impact factor: 4.792

2. Isolation and characterization of bacteriophages infecting Xanthomonas arboricola pv. juglandis, the causal agent of walnut blight disease.

Authors: Sandra Romero-Suarez; Brian Jordan; Jack A Heinemann
Journal: World J Microbiol Biotechnol Date: 2012-01-07 Impact factor: 3.312

Review 3. Platforms for antibiotic discovery.

Authors: Kim Lewis
Journal: Nat Rev Drug Discov Date: 2013-05 Impact factor: 84.694

4. Genomic and Biochemical Characterization of Acinetobacter Podophage Petty Reveals a Novel Lysis Mechanism and Tail-Associated Depolymerase Activity.

Authors: A C Hernandez-Morales; L L Lessor; T L Wood; D Migl; E M Mijalis; J Cahill; W K Russell; R F Young; J J Gill
Journal: J Virol Date: 2018-02-26 Impact factor: 5.103

Phage-inspired antibiotics?

1. Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms.

2. Isolation and characterization of bacteriophages infecting Xanthomonas arboricola pv. juglandis, the causal agent of walnut blight disease.

Review 3. Platforms for antibiotic discovery.

4. Genomic and Biochemical Characterization of Acinetobacter Podophage Petty Reveals a Novel Lysis Mechanism and Tail-Associated Depolymerase Activity.

5. Phage Therapy: Future Inquiries.

6. In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.

7. Biophysical studies of the interactions between the phage varphiKZ gp144 lytic transglycosylase and model membranes.

8. Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection.

9. A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.

10. Dispersing biofilms with engineered enzymatic bacteriophage.